about
Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesNF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy targetTargeting A20 decreases glioma stem cell survival and tumor growth.In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.Colorectal cancer and NF-κB signaling pathwayArenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola.Mechanisms of geomagnetic field influence on gene expression using influenza as a model system: basics of physical epidemiologyFijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus NocardiopsisFunctional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains.Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbilsNovel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2).Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agentsCurcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null miceRAGE signaling sustains inflammation and promotes tumor development.NF-kappa B as a target for cancer therapy.NF-kappaB activation in development and progression of cancer.NF-kappa B: a new player in angiostatic therapyTargeting intracellular signaling: a novel approach to vaccination.Apoptotic cells can induce non-autonomous apoptosis through the TNF pathwayEndogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma.IκBζ: an emerging player in cancer.Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodiesNF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.Emerging pathways and future targets for the molecular therapy of pancreatic cancer.Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems.Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression.Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-κB-mediated bcl-2 activation.Nuclear factor-kappa B inhibition reduces markedly cell proliferation in Epstein-Barr virus-infected stomach cancer, but affects variably in Epstein-Barr virus-negative stomach cancer.Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer.Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice.Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival.
P2860
Q28540187-BEFA5D05-3A84-4AC7-9AAE-BE92B77A4A14Q28611413-FCD3395E-2E79-4A5F-BAF6-732E1F6290C6Q33534629-AED67599-29A5-4003-BBA0-424B9903933CQ33546150-4934327E-838B-40A4-80AE-E72AA42DB872Q33596306-E6EDF4A4-D55F-495D-A780-342D02FBBBAFQ33721939-67430BE2-4975-4F14-B76F-612BEE349130Q33858765-56E91E5C-A2C5-41EE-BEEB-E399FB5026CFQ33982435-7F77F6DD-1C44-47B1-A65A-5C9E1BB84242Q35087443-4699B051-F87D-481A-AA9E-D1C68375947CQ35091196-EA3C84CA-E77C-425A-A345-F8D19EB9AD21Q35516227-A8F13B24-6150-49E3-B742-9F4B3351FB73Q35813325-02FB0891-93A6-47A4-B541-1D79F989FDE0Q35977804-5664D3BA-5053-464E-AFE8-7B89D18382F4Q36151692-4C5A36A5-41B8-48E5-99C3-531ACCA7A044Q36420128-E1769ED0-7C3E-48F9-9FDB-26751ED99045Q36502858-1915F938-D72C-4B43-B51F-515E05532442Q36709532-AF0C6036-EFEA-4663-8648-1D76016CE59CQ36725293-65540EE1-B8C0-40C6-8482-21D38AE84F5DQ37088045-A53C3C34-D922-4A7A-9A33-FD7F35ECC2E5Q37123459-8BE5BFE0-FCC1-4F26-B24F-A875FDBBCBE0Q37188252-A8F48906-7A88-42BC-947A-B26434514CD9Q37229916-FAD8222B-6816-4471-976F-C042E07BCEC6Q37428076-F4724ADB-3221-4F57-A5D6-FA6B08850836Q37662411-5D15DCD5-57BC-4021-8CCC-60D1CBDF168CQ37725333-27A1E499-AA9A-4A64-80BE-77AA0078F418Q37790694-FF7D1130-2037-48EB-8166-1B5C89DB2C01Q37912219-0774DCB5-5096-4B35-B3D4-C21363E48186Q38846785-2F559C01-CF29-423F-B498-2259397A946EQ39065656-5A1BED02-6AD4-4623-B513-156C0B4D8217Q39522772-D4321119-4561-40D7-9A48-69438BEE5A87Q39529244-916634DD-0C6F-4EA5-90F6-518A1857A0D9Q39766076-9C51C386-DB88-4CE2-B38E-95724E85CA55Q40751673-CFE2C3DF-ED22-41BD-AAD9-55D56142EA35Q40785717-F1F6B173-0AF4-4711-90DF-CA56C6A67078Q42512337-EF120BB3-AC04-47A4-B40D-6D14DEB661B4Q44519577-E7550EEE-A8EC-4B6D-8183-37E042A8F7C5Q46498246-B56DD003-6974-4F0A-9E80-F954911BE6ADQ52723706-99CF7E77-2AA1-46F4-9531-4B2A1E48C361
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
NF-kappaB inhibition: a double-edged sword in cancer?
@ast
NF-kappaB inhibition: a double-edged sword in cancer?
@en
NF-kappaB inhibition: a double-edged sword in cancer?
@nl
type
label
NF-kappaB inhibition: a double-edged sword in cancer?
@ast
NF-kappaB inhibition: a double-edged sword in cancer?
@en
NF-kappaB inhibition: a double-edged sword in cancer?
@nl
prefLabel
NF-kappaB inhibition: a double-edged sword in cancer?
@ast
NF-kappaB inhibition: a double-edged sword in cancer?
@en
NF-kappaB inhibition: a double-edged sword in cancer?
@nl
P1476
NF-kappaB inhibition: a double-edged sword in cancer?
@en
P2093
Eli Pikarsky
Yinon Ben-Neriah
P304
P356
10.1016/J.EJCA.2006.01.011
P407
P577
2006-04-01T00:00:00Z